➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: April 10, 2021

DrugPatentWatch Database Preview

MOTRIN IB Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Motrin Ib, and when can generic versions of Motrin Ib launch?

Motrin Ib is a drug marketed by J And J Consumer Inc and is included in one NDA.

The generic ingredient in MOTRIN IB is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Motrin Ib

A generic version of MOTRIN IB was approved as ibuprofen by OHM on July 15th, 1986.

  Start Trial

Summary for MOTRIN IB
US Patents:0
Suppliers / Packagers: 3
Bulk Api Vendors: 175
Clinical Trials: 44
Patent Applications: 4,284
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in MOTRIN IB?MOTRIN IB excipients list
DailyMed Link:MOTRIN IB at DailyMed
Drug patent expirations by year for MOTRIN IB
Recent Clinical Trials for MOTRIN IB

Identify potential brand extensions & 505(b)(2) entrants

National Cancer Institute (NCI)Phase 1
City of Hope Medical CenterPhase 1
Boston UniversityPhase 4

See all MOTRIN IB clinical trials

US Patents and Regulatory Information for MOTRIN IB

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc MOTRIN IB ibuprofen TABLET;ORAL 019012-003 Dec 17, 1990 OTC Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.